Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129175) titled 'A Prospective Cohort Study Comparing Surgical Outcomes and Prognostic Factors in Patients with Clinical T3a Renal Cell Carcinoma' on July 31.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Chinese PLA General Hospital
Condition:
renal cell carcinoma
Intervention:
Partial nephrectomy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Partial nephrectomy group:32;Radical nephrectomy group:32;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335314
Published by HT...